International Scientific Forum on Alcohol Research Critique 143: Is Alcohol's Cardio-Protective Effect Still Valid?
By International Scientific Forum on Alcohol Research | 21 July 2014
A recent paper, which uses a very large dataset from subjects of European descent, uses a Mendelian randomisation analysis to estimate the effects of alcohol consumption on cardiovascular disease (CVD), using as the instrumental variable an uncommon allele affecting alcohol metabolism, the ADH1B rs1229984 variant.
People with this variant are unusually sensitive to alcohol (developing flushes and other uncomfortable symptoms from alcohol) and it has been well-demonstrated that they are less likely than people without this variant to consume alcohol, and are unlikely to be heavy drinkers. The authors conclude that, since the 7% of their subjects with the uncommon allele had less CVD, this indicates that alcohol consumption is unrelated to CVD.
Our forum members agree that the analyses were done correctly, but strongly disagree with the premise of the study and the conclusions of the authors. They also consider the genetic factor chosen as inappropriate to use as the instrumental variable in Mendelian randomisation.
The gene studied explains only a fraction of alcohol consumption in the population (not stated in the paper) and it may have effects on CVD beyond those explained by alcohol consumption. Thus, this ADH1b allele violates the assumptions required for a variable for Mendelian randomisation and would be inappropriate for judging the effects of alcohol on CVD. Further, in the present study, the authors report little relation of their estimate of alcohol consumption with HDL-cholesterol, while essentially all observational studies, clinical trials, and experimental studies have shown that alcohol is an important determinant of HDL.
This further suggests that the use of the ADH1B allele provides an inadequate estimate of alcohol consumption.
Even without the weakness of the allele chosen to reflect alcohol effects, conclusions derived from Mendelian randomisation in general are heavily dependent on the assumption that the instrumental chosen is appropriate, of which you can rarely be confident. Forum reviewers consider this method to be a very blunt instrument and subject to considerable bias for variables that are weakly correlated with exposure and not true instruments.
Some reviewers were concerned by the conclusion of the authors that this Mendelian randomisation paper suggests that all persons should drink less.
The protection of moderate drinking against CVD that is generally observed shows a non-linear gradient; protection is strongest at low regular alcohol consumption levels, while it is less strong as the consumption levels rise above optimum and finally disappears and is transformed into harm with heavy alcohol consumption.
This would be in agreement with the conclusions of most prospective studies and meta-analyses that drinking alcohol at low doses offers the best protection against CVD, as there is a J-shaped curve.
To read the full critique, click here.
These critiques are published with the permission of The ISFAR.
- It's not all bad for Diageo - Analysis
- Focus - Diageo's FY Performance by Brand
- Diageo upbeat on Scotch prospects
- Heineken CEO spies trouble ahead for UK
- Soft Drinks Has The Bottle to Cut Sugar - Comment
- Diageo puts Bacardi in frame with white rum ads
- Edrington appoints new board director
- Heineken ups sales, profits despite volume squeeze
- Challenges remain as Diageo posts flat FY sales
- Mast-Jagermeister closes Sidney Frank buy
- Global gin insights - market data, product innovation and consumer trends research
- Global rum insights - market forecasts, product innovation and consumer trends research
- Global Tequila insights - market forecasts, product innovation and consumer trends research
- Global Scotch whisky insights - market forecasts, product innovation and consumer trends research
- Global cachaca insights - market data, product innovation and consumer trends research